Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brazil tightens successful malaria campaign:

This article was originally published in Clinica

Executive Summary

Brazil has reported significant successes in its malaria control programme, two years after its launch. During a recent meeting to approve plans to strengthen the programme, the Brazilian healthcare foundation - Fundacao Nacional de Saude (Funasa) - reported a 70% fall in the incidence of malaria since 1999 across the Amazonia Legal region. Of the eight states in the region, Mato Grosso and Roraima recorded the highest falls, at 76.9% and 74.9%, respectively. the success has been attributed to a significant investment in epidemiological surveillance. The incidence of the disease remains high, however. In the year to August, 186,100 cases had been reported across the region this year. Funasa estimates that around 300,000 new cases will be diagnosed in 2002, compared with 387,200 in 2001 and 635,600 in 1999. The malaria plan was launched in July 2000, backed by annual funding totalling R$146m (US$37m).

Topics

UsernamePublicRestriction

Register

MT068520

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel